2022. High-risk Neuroblastoma in Young Adult and Long Term Survival with Multimodal Therapy: A Case Report. International Journal of Integrated Health Sciences. 10, 2 (Sep. 2022), 102–106. DOI:https://doi.org/10.15850/ijihs.v10n2.2868.